Hypnion, Inc.

Hypnion, Inc. (Hypnion) is a neuroscience drug discovery company and operates as a subsidiary of Eli Lilly and Company. The company develops therapeutics for the treatment of central nervous system (CNS) disorders including sleep and wake-alertness disorders and circadian rhythm abnormalities. These therapeutic drugs are developed based on the drug discovery technology namely, SCORE-2004. It is a predictive sleep-wake bioassay system. Hypnion has a product under development which is a Novel Sleep Drug - HY10275. In addition, The company has a partnership with the Oxford Bioscience which is an life science venture capital firm. The company is headquartered in Massachusetts, the US.

Street: 
500 Patriot Way
City: 
Lexington
Postcode: 
02421
Federal State : 
United States
WebSite: 
www.hypnion.com
Fax: 
1-781-7780303

Company Index Score

Current Index Score Historical Index Score
  • Hypnion, Inc. currently scores 50 % in the index.
  • Hypnion, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Hypnion, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets